Current and Emerging Treatment Regimens for HER2-Positive Breast Cancer
Abstract:
Overexpression of human epidermal growth factor receptor 2 (HER2) is an important factor in cancer survival, proliferation, and metastasis. Agents that target HER2-positive tumors are used with traditional chemotherapies, with other targeted therapies, or as monotherapy to treat metastatic breast cancers.
Insights
Overexpression of the human epidermal growth factor receptor 2 (HER2) drives cancer progression. Therapies targeting HER2-positive cancers are crucial for treating metastatic breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Overexpression of human epidermal growth factor receptor 2 (HER2) is a significant factor influencing cancer survival, proliferation, and metastasis.
- HER2-positive tumors represent a distinct subtype of cancer requiring specific therapeutic strategies.
Purpose of the Study:
- To review the role of HER2 in cancer progression.
- To discuss the therapeutic strategies targeting HER2-positive tumors.
Main Methods:
- Literature review of studies on HER2 in cancer.
- Analysis of clinical data on HER2-targeted therapies.
Main Results:
- HER2 overexpression is linked to poorer prognosis and increased metastatic potential.
- Targeted agents show efficacy in HER2-positive metastatic breast cancer.
Conclusions:
- Targeting HER2 is a validated approach in oncology.
- Combination therapies and monotherapy with HER2 agents are vital for managing metastatic breast cancer.
Related Concept Videos
02:57Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
02:57Targeted Cancer Therapies
1.4K
1.4K
02:56Treatment Resistent Cancers
1.1K
1.1K
02:56Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
02:49Cancer Therapies
2.4K
2.4K